Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from JCR Pharmaceuticals Co., Ltd. ( (JP:4552) ) is now available.
JCR Pharmaceuticals’ latest financial results reveal a significant decline in performance, with net sales dropping by 23.2% and a shift from profit to a loss in operating and ordinary profits. The company’s comprehensive income also fell sharply, indicating potential challenges in maintaining its previous growth trajectory.
More about JCR Pharmaceuticals Co., Ltd.
JCR Pharmaceuticals Co., Ltd. operates in the pharmaceutical industry with a focus on the development and manufacturing of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is part of the general business category.
YTD Price Performance: -6.10%
Average Trading Volume: 369,071
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: Yen70.54B
For detailed information about 4552 stock, go to TipRanks’ Stock Analysis page.